Lum/iva - OmicsDI

Show results for

Unknown (15)
Proteomics (1)
Genomics (1)

Organisms

Alphavirus (1)
Betaherpesvirinae (1)
Brassica oleracea var. oleracea (1)
Cowpox virus (1)
Coxsackievirus (1)
Cytomegalovirus (1)
Dengue virus (1)
EFO:0001352 (1)
Filoviridae (1)
Hepatitis B virus (1)
Human alphaherpesvirus 1 (1)
Human betaherpesvirus 5 (1)
Human immunodeficiency virus 1 (1)
Human immunodeficiency virus 2 (1)
Influenza A virus (1)
Influenza C virus (1)
Japanese encephalitis virus (1)
Japanese encephalitis virus group (1)
Lyssavirus rabies (1)
Monkeypox virus (1)
Nostoc sp. PCC 7120 = FACHB-418 (1)
Oropouche virus (1)
Orthopoxvirus (1)
Orthopoxvirus vaccinia (1)
Rattus (1)
Ruditapes decussatus (1)
Tick-borne encephalitis virus (1)
Viruses (1)
West Nile virus (1)
spotted fever group (1)

Repository

pride (1)
ENA (1)

Tissue

Blood plasma (1)
Blood serum (1)
Sputum (1)

Disease

Cystic fibrosis (1)

Technology Type

Bottom-up proteomics (1)
Data-independent acquisition (1)
Mass Spectrometry (1)

Publication Date

2026 (1)

Release Date

2019 (4)
2025 (3)
2022 (3)
2021 (3)
2023 (2)

Lab affiliation

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. Berlin Institute of Health (BIH), Berlin, Germany. (1)

First Public Date

2025 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Systemic effects of cystic fibrosis transmembrane conductance regulator (CFTR) modulators on the plasma and serum proteome

Cystic fibrosis (CF), resulting from a dysfunction in the cystic fibrosis transmembrane conductance regulator (CFTR), affects multiple organs through mucus obstruction and differences in secretion. The CFTR modulator drug combination elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA, ETI) has markedly i...

ORGANISM(S): Homo sapiens (Human)

2026-04-14 | PXD071549 | Pride